We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Longitudinal Laboratory Data Predicts Complication in Crohn’s Disease Patients

By LabMedica International staff writers
Posted on 27 Sep 2022
Print article
Image: Histopathology of Patient with Crohn\'s disease showing evidence of an epithelioid nonnecrotizing granuloma (Photo courtesy of Catherine E. Hagen, MD and Luisa Ricaurte Archila, MD)
Image: Histopathology of Patient with Crohn\'s disease showing evidence of an epithelioid nonnecrotizing granuloma (Photo courtesy of Catherine E. Hagen, MD and Luisa Ricaurte Archila, MD)

Stenosis, fistulization, and perforation of the bowel are severe outcomes which can occur in patients with Crohn’s disease. Accurate prediction of these events may enable clinicians to alter treatment strategies and avoid these outcomes.

Crohn’s disease is a chronic inflammatory condition of the human gastrointestinal tract of undetermined etiology. It is characterized by a relapsing and remitting course and by significant morbidity from chronic abdominal pain, diarrhea, and perianal abscesses.

Gastroenterologists at the Royal Brisbane and Women’s Hospital (Brisbane, Australia) and their colleagues studied the correlation between longitudinal laboratory testing and subsequent intestinal complications in 246 patients with Crohn’s disease. This was an observational cohort of patients with Crohn’s disease at a single center were analyzed between 01/01/1994 and 06/30/2016. A complication was defined as the development of an intestinal fistula, stenosis, or perforation.

The team analyzed C-reactive protein (CRP, (mg/L), erythrocyte sedimentation rate (ESR, mm/h), hemoglobin level (g/L), mean cell volume (MCV, fL), white blood cell count (WCC, × 109/L), platelet count (× 109/L), neutrophil count (× 109/L), fecal calprotectin (mcg/g feces), ferritin (mcg/L), alanine transferase (ALT, IU/L), and albumin (g/L).

The scientists reported that n 246 patients they observed over a median of 5.72 years, 134 complications occurred. Minimum or maximum value in a preceding window period of one year was most strongly associated with subsequent complication. A Longitudinal Laboratory score of ≥ 2 (maximum albumin level < 39 g/L = 1, maximum mean cell volume < 88 fL = 1, minimum platelet count > 355 × 109/L = 1, minimum C reactive protein > 5 mg/L = 1) was 62% sensitive and 91% specific in identifying patients who develop a subsequent complication. A Longitudinal Laboratory score ≥ 2 predicted the development of a future complication, with a positive predictive value of 84%, and a negative predictive value of 76%.

The authors concluded that consistently reduced serum albumin and MCV, and consistently increased CRP and platelet count are associated with future development of complications in patients with Crohn’s disease. These laboratory changes are observed up to two years prior to the development of a complication. In addition to recognized markers of poor outcome in Crohn’s disease, longitudinal laboratory tests may be assessed and used to provide a rationale for timely escalation of therapy. The study was published on September 20 2022 in the journal Digestive Diseases and Sciences.

Related Links:
Royal Brisbane and Women’s Hospital

Gold Supplier
Group A Streptococcus Antigen Test
OSOM Strep A Test
Albumin Urine Test
Micro-Albumin ELISA
Direct LDL Assay
Direct LDL-C
Trypanosoma Brucei Gambiense Antibody Test
HAT Sero K-SeT

Print article


Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more


view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more


view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.